Rui Medeiros | Professor & Cancer Researcher

Is a leading global oncology expert committed to connecting molecular science with public health. As Professor and senior researcher at IPO Porto (Portuguese Oncology Institute of Porto), his work focuses on precision medicine and cancer prevention at scale.

 

Core Expertise & Research

With over 510 publications, Professor Medeiros specializes in pharmacogenomics and personalized medicine, aiming to tailor cancer treatments to individual genetic profiles. Key research areas include:

• HPV & Women’s Health: Advancing HPV vaccine efficacy and understanding cervical and ovarian cancer mechanisms.
• Oncogenetics: Studying genetic predispositions in prostate and lung cancers for early detection.
• Precision Medicine: Using biomarkers to predict treatment response, optimizing therapies while minimizing toxicity.

 

Leadership in Tobacco Control

A strong advocate for public health, Medeiros is a prominent voice against tobacco-related diseases. He has been instrumental in shaping European policy through:

• ECTOH Summits: Organizer and speaker at ECTOH Porto 2017 and Madrid 2023, promoting tobacco endgame strategies.
• Madrid Charta: Signatory and advocate for stricter legislation toward a tobacco-free generation.
• Research Impact: Linking molecular damage from tobacco to lung cancer, reinforcing prevention laws.

 

Advocacy & Global Impact

Beyond research, Medeiros collaborates with Liga Portuguesa Contra Cancro/European Cancer Leagues and the European Cancer Organization to democratize cancer education and screening. His mission combines cutting-edge personalized medicine with robust prevention programs to reduce the global cancer burden through innovation and policy change. JA EUnetCCC and JA PCM member.

ScholarGPS® ID: 28369051609188
https://orcid.org/0000-0003-3010-8373 | https://sciprofiles.com/user/publications/34941